In vivo hippocampal 31P NMR metabolites in Alzheimer's disease and ageing

European Psychiatry

Volumn 12, Issue 3, 1997, Pages 140-148

  Mecheri, G ^a   Marie Cardine, M ^a   Sappey Marinier, D ^b   Bonmartin, H ^b   Albrand, G ^b   Ferry, G ^b   Coppard Meyer, N ^b   Courpron, P ^b  

^a UNIVERSITÉ LYON 1   (France)

^b NONE

Author keywords

ageing; Alzheimer's disease; P31 NMR spectroscopy

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; METABOLITE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 0030922106     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)80203-9     Document Type: Article

References (53)

1. Alavi A, Dann R, Chawluk J et al. Positron emission tomography imaging of regional cerebral glucose metabolism. Semin Nucl Med 1986;16:2-34
2. Arispe N, Pollard HB, Rojas E. Giant multilevel cation channels formed by Alzheimer's disease amyloid beta-protein (a beta P-1-40) in bilayer membranes. Proc Natl Acad Sci USA 1993;90:10573-7
3. Bartus RT, Dean III RL, Beer B et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-17
4. Baumann K, Mandelkow EM, Biernat J et al. Abnormal Alzheimer-like phosphorylation of Tau protein by cyclin-dependent Kinases Cdk2 and Cdk5. FEBS Lett 1993; 336:417-24
5. Beal MF. Aging, energy and oxidative stress in neurodegenetative diseases. Ann Neurol 1995;38:357-66
6. Boller F, Becker JT, Holland AL et al. Predictors of decline in Alzheimer's disease. Cortex 1991;27:9-17
7. Bothmer J, Jolles J. Phosphoinositide metabolism, aging and Alzheimer's disease. Biochemica et Biophysica Acta 1994; 1225:111-24
8. Bothmer J, Markerink M, Jolles J. Evidence for a selective decrease in type I Phosphatidylinositol Kinase activity in brains of patients with Alzheimer's disease. Dementia 1994;5:6-11
9. Bottomley PA, Cousins JP, Pendrey DL et al. Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology 1992;183:695-9
10. Brown CG, Levine SR, Gorell JM et al. In vivo P31 NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 1989;39:1423-7
11. Chandrasekaran K, Hatanpaa K, Brady DR et al. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's Disease. Exp Neurol 1996;142:80-8
12. Cuenod CA, Kaplan DB, Michot JL et al. Phospholipid abnormalities in early Alzheimer's disease. Arch Neurol 1995; 52:89-94
13. Deiken RF, Calabrese G, Raz J et al. A 31 phosphorus magnetic resonance spectroscopy study of diazepam does not affect brain phosphorus metabolism. Biol Psychiatry 1992; 32:628-31
14. DeLeon MJ, Golomb J, Convit A et al. Measurement of medial temporal lobe atrophy in diagnosis of Alzheimer's disease. The Lancet 1993;341:125
15. Eimerl S, Schramm M. The quantity of Calcium that appears to induce neuronal death. J Neurochem 1994;62:1223-6.
16. Farooqui AA, Horrocks LA. Metabolic and functional aspects of neural membrane phospholipids. In: Horrocks LA et al, eds. Phospholipids in the nervous system. New York: Raven Press, 1985;2:341-8
17. Farooqui AA, Liss L, Horrocks LA. Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids. Met Brain Dis 1988;3:19-35
18. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-98
19. Fukuyama H, Kameyama M, Harada K et al. Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan. Acta Neurol Scand 1989;80:307-13
20. Colomb J, Kluger A, DeLeon MJ et al. Hippocampal formation size predicts declining memory performance in normal aging. Neurology 1996;47:810-13
21. Gonzalez RG, Guimaraes AR, Moore GJ et al. Quantitative In Vivo 31P Magnetic Resonance Spectroscopy of Alzheimer's Disease. Alzheimer Disease and Associated Disorders 1996;10:46-57
22. Hachinski VC, Illif LD, Phill M et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62
24. Haxby JV, Grady CL, Koss E et al. Heterogeneous anterior-posterior metabolic patterns in Dementia of The Alzheimer Type. Neurology, 1988;38:1853-63
25. Hubesch B, Sappey-Marinier D, Deiken R et al. Regional differences of phosphorus metabolites in the human brain. In: Society of Magnetic Resonance in Medecine, ed. Book of Abstracts. Berkeley: 1989;1:447
26. Hyman BT, Penney JB, Blackstone CD et al. Localization of non-N-Methyl-D-Aspartate glutamate receptors in normal and Alzheimer hippocampal formation. Ann Neurol 1993;35:31-7
27. Hyman BT, Van Hoesen GW, Damasio AR. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 1987;22:37-40
28. Hyman BT, Van Hoesen GW, Damasio A et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;255:1168-70
29. Jobst KA, Smith AD, Szatmari M et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy. The Lancet 1992;340: 1179-83
30. Kanfer JN, Hattori H, Orihel D. Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients. Ann Neurol 1986;20:265-7
31. Kanfer JN, Pettegrew JW, Moossy J et al. Alterations of selected enzymes of phospholipid metabolism in Alzheimer's disease brain tissue as compared to non-Alzheimer's disease controls. Neurochem Res 1993; 18: 331-4
32. Kuhl DE, Minoshima S, Fessler JA et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's Disease and Parkinson's Disease. Ann Neurol 1996;40:399-410
33. Lehninger AL. Biochemistry. New York: Worth, 1975;2nd ed
34. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report on the NINCDS-ADRDA workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44
35. Mecheri G, Marie-Cardine M. In Vivo metabolic study with NMR spectroscopy in Alzheimer's Disease. In: Macher JP, Crocq MA, Nedelec F, eds. New Prospects in Psychiatry: The Bioclinical Interface & The Mapping Brain Function. Roussach: John Libbey Evrotext, John Libbey Eurotext, 1994;357-62
36. Miller BL, Read S, Tang C et al. Differences in red blood cell choline and lipid-bound choline between patients with Alzheimer's disease and control subjects. Neurobiol Aging 1991;12:61-4
37. Murphy DGM, Bottomley PA, Salerno JA et al. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry 1993;50:341-9
38. Nitsch RM, Blusztajn JK, Pittas AG et al. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 1992;89:1671-5
39. Ordidge RJ, Connely A, Lohman JAB. Image-selected in vivo spectroscopy (ISIS): a new technique for spatially selective NMR spectroscopy. J Magn Reson 1986;66:283-94
40. Petroff OA, Prichard JW, Behar KL et al. Cerebral intracellular pH by 31P magnetic resonance spectroscopy. Neurology 1985;35:781-8
41. Pettegrew JW. Molecular insights into Alzheimer's disease. Proc NY Acad Sci 1989;568:5-28
42. Pettegrew JW, Minshew NJ, Cohen MM et al. P-31 NMR changes in Alzheimer's and Huntington's disease brain. Neurology 1984;34(Suppl 1):281
43. Pettegrew JW, Panchalingam K, Klunk WE et al. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol Aging 1994;15:117-32
44. Rapoport SI. Anatomic and functional brain imaging in Alzheimer's disease. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press Ltd, 1995;1401-15
45. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14
46. Roth GS, Joseph JA, Mason RP. Membranes alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci 1995;18:203-6
47. Samuel D, Heron DS, Herschkowitz M et al. Aging, receptor binding and membrane viscosity. In: Giacobini E, Vernadakis A, eds. The aging brain: cellular and molecular mechanisms of aging in the nervous system. New York: Raven Press, 1982;93-7
48. Smith CD, Pettegrew LC, Avison MJ et al. Frontal lobe phosphorus metabolism and neuropsychological function in Aging and in Alzheimer's disease. Ann Neurol 1995;38: 194-201
49. Traill, KN, Wick G. Lipids and lymphocyte function. Immunol Today 1984;5:70-6
50. Tucek S. Regulation of acetylcholine synthesis in the brain. J Neurochem 1985;44:11-24
51. Welch KMA. 31P in vivo spectroscopy of adult human brain. In: Pettegrew JW, ed. NMR: principles and applications to biomedical research. New York: Springer-Verlag, 1990; 429-67
52. Wells K, Farooqui AA, Liss L et al. Neural membrane phospholipids in Alzheimer's Disease. Neurochem. Res 1995; 20:1329-33
53. West MJ, Coleman PD, Flood DG et al. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. The Lancet 1994;344:769-72